UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

Lancet neurology, 2013-04, Vol.12 (4), p.346-356

2013

Link zum Volltext

Verfügbarkeit prüfen

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

Movement disorders, 2011-10, Vol.26 (12), p.2246-2252

2011

Link zum Volltext

Verfügbarkeit prüfen

Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial

Mayo Clinic proceedings, 2003-06, Vol.78 (6), p.687-695

2003

Link zum Volltext

Verfügbarkeit prüfen

Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients

Parkinsonism & related disorders, 2014-12, Vol.20 (12), p.1335-1340

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials

The Lancet (British edition), 2006-09, Vol.368 (9539), p.929-937

2006

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

Parkinsonism & related disorders, 2014-02, Vol.20 (2), p.142-148

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis

Clinical neuropharmacology, 2018-03, Vol.41 (2), p.47-55

2018

Link zum Volltext

Verfügbarkeit prüfen

Analgesic Efficacy of Peripheral κ-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model: Selective Effect on Visceral Pain

Anesthesiology (Philadelphia), 2009-09, Vol.111 (3), p.616-624

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

CNS drugs, 2015-04, Vol.29 (4), p.341-350

2015

Link zum Volltext

Verfügbarkeit prüfen

Measures of Disease Control in Medicare Beneficiaries with Diabetes Mellitus

Journal of the American Geriatrics Society (JAGS), 1999-04, Vol.47 (4), p.417-422

1999

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Strength Conditioning on Older Women's Ability to Perform Daily Tasks

Journal of the American Geriatrics Society, 1995-07, Vol.43 (7), p.756-760

1995

Link zum Volltext

Verfügbarkeit prüfen

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

Journal of the neurological sciences, 2017-02, Vol.373, p.116-123

2017

Link zum Volltext

Verfügbarkeit prüfen

A Population Pharmacokinetic and Pharmacodynamic Study of a Peripheral [kappa]-Opioid Receptor Agonist CR665 and Oxycodone

Clinical pharmacokinetics, 2013-02, Vol.52 (2), p.125

2013

Link zum Volltext

Verfügbarkeit prüfen

A Population Pharmacokinetic and Pharmacodynamic Study of a Peripheral κ-Opioid Receptor Agonist CR665 and Oxycodone

Clinical pharmacokinetics, 2013-02, Vol.52 (2), p.125-137

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial

Annals of internal medicine, 1998-11, Vol.129 (9), p.681

1998

Link zum Volltext

Verfügbarkeit prüfen

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials

Journal of Parkinson's disease, 2015-01, Vol.5 (4), p.837

2015

Link zum Volltext

Verfügbarkeit prüfen

Analgesic Efficacy of Peripheral κ-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model

Anesthesiology (Philadelphia), 2009-09, Vol.111 (3), p.616-624

2009

Link zum Volltext

Verfügbarkeit prüfen

Association Between Alzheimer's Disease and Bound Autochthonous IgM on T Cells

Journal of the American Geriatrics Society (JAGS), 1996-11, Vol.44 (11), p.1362-1365

1996

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

International Urogynecology Journal, 2006-10, Vol.17 (5), p.502-511

2006

Link zum Volltext

Verfügbarkeit prüfen

740: Efficacy and Tolerability of Dapoxetine in the Treatment of Premature Ejaculation

The Journal of urology, 2005-04, Vol.173 (4), p.201-202

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Warfarin When Coadministered With Pentosan Polysulfate Sodium

Journal of clinical pharmacology, 2005-08, Vol.45 (8), p.919-926

2005

Link zum Volltext

Verfügbarkeit prüfen

877: Dapoxetine for the Treatment of Men with Premature Ejaculation (PE): Dose-Finding Analysis

The Journal of urology, 2005-04, Vol.173 (4), p.238-238

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation : an integrated analysis of two double-blind, randomised controlled trials. Commentary

The Lancet (British edition), 2006, Vol.368 (9539)

2006

Link zum Volltext

Verfügbarkeit prüfen

Diabetes care for Medicare beneficiaries. Attitudes and behaviors of primary care physicians

Diabetes care, 1998-08, Vol.21 (8), p.1282

1998

Link zum Volltext

Verfügbarkeit prüfen

Oxybutynin chloride: alterations in drug delivery and improved therapeutic index

Expert opinion on pharmacotherapy, 2002-04, Vol.3 (4), p.443-454

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial

Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis

Analgesic Efficacy of Peripheral κ-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model: Selective Effect on Visceral Pain

Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

Measures of Disease Control in Medicare Beneficiaries with Diabetes Mellitus

The Effects of Strength Conditioning on Older Women's Ability to Perform Daily Tasks

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

A Population Pharmacokinetic and Pharmacodynamic Study of a Peripheral [kappa]-Opioid Receptor Agonist CR665 and Oxycodone

A Population Pharmacokinetic and Pharmacodynamic Study of a Peripheral κ-Opioid Receptor Agonist CR665 and Oxycodone

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials

Analgesic Efficacy of Peripheral κ-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model

Association Between Alzheimer's Disease and Bound Autochthonous IgM on T Cells

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

740: Efficacy and Tolerability of Dapoxetine in the Treatment of Premature Ejaculation

Pharmacokinetics and Pharmacodynamics of Warfarin When Coadministered With Pentosan Polysulfate Sodium

877: Dapoxetine for the Treatment of Men with Premature Ejaculation (PE): Dose-Finding Analysis

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation : an integrated analysis of two double-blind, randomised controlled trials. Commentary

Diabetes care for Medicare beneficiaries. Attitudes and behaviors of primary care physicians

Oxybutynin chloride: alterations in drug delivery and improved therapeutic index

Suchergebnisse filtern